FDA Drug Application (021120) for NOVANTRONE by SERONO INC

Back to FDA Applications sponsored by SERONO INC

Application Number021120
Product Number001
FormINJECTABLE; INJECTION
DosageEQ 2MG BASE/ML
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameNOVANTRONE
Active IngredientMITOXANTRONE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient MITOXANTRONE HYDROCHLORIDE2


Back to FDA Applications sponsored by SERONO INC